1
Primary outcome is a composite measure of severe neonatal morbidity and mortality.
2
The primary outcome measure will be a composite neonatal morbidity and mortality.
3
After adjusting for confounders, no predictors were associated with composite neonatal morbidity.
4
Main outcome measures: Perinatal mortality, composite neonatal morbidity and premature delivery.
5
Background: Omphalitis contributes to neonatal morbidity and mortality in developing countries.
6
Conclusion: Intrapartum fever is an important predictor of neonatal morbidity and infection-related mortality.
7
Conclusions: The SR and the SF methods had low sensitivities for neonatal morbidity.
8
Secondary outcomes were maternal and neonatal morbidity and time from intervention to birth.
9
Background: Preterm birth is the most common cause of neonatal morbidity and mortality.
10
Secondary outcomes were maternal and neonatal morbidity and time to birth.
11
The rates of neonatal morbidity did not differ between the groups.
12
Conclusion: 17a-hydroxyprogesterone caproate does not prevent neonatal morbidity or preterm birth in multiple pregnancies.
13
Secondary outcomes are mode of delivery, maternal and neonatal morbidity, costs and women's preference.
14
The unadjusted neonatal morbidity rate was highest in South Asian-born women at most gestations.
15
There were no significant differences in their infants' birth data or rates of neonatal morbidity.
16
Introduction: Research suggests that neonatal morbidity differs by maternal region of birth at different gestational ages.
